Anabolic effect of β-cryptoxanthin in osteoblastic MC3T3-E1 cells is enhanced with 17 β-estradiol, genistein, or zinc sulfate in vitro: The unique effect with zinc on Runx2 and α1(I) collagen mRNA expressions

Molecular and Cellular Biochemistry

Volumn 307, Issue 1-2, 2008, Pages 209-219

  Uchiyama, Satoshi ^a   Yamaguchi, Masayoshi ^a,b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Institute of Bone Health and Nutrient   (Japan)

Author keywords

Cryptoxanthin; 17 Estradiol; Genistein; Menaquinone 7; Osteoblastic cell; Zinc

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ALKALINE PHOSPHATASE; BETA CRYPTOXANTHIN; CALCITRIOL; COLLAGEN TYPE 1; CYCLOHEXIMIDE; ESTRADIOL; GENISTEIN; MENAQUINONE; MESSENGER RNA; OSTEOCALCIN; PROTEIN SYNTHESIS INHIBITOR; TRANSCRIPTION FACTOR RUNX2; ZINC SULFATE;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN CONTENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION TERMINATION;

ANABOLIC AGENTS; ANIMALS; CALCITRIOL; CELLS, CULTURED; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DRUG SYNERGISM; ESTRADIOL; GENE EXPRESSION REGULATION; GENISTEIN; MICE; OSTEOBLASTS; RNA, MESSENGER; VITAMIN K 2; XANTHOPHYLLS; ZINC SULFATE;

BOVINAE;

EID: 36949004530     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9600-9     Document Type: Article

References (33)

1. Cooper C, Melton J III (1995) Epidemiology of osteoporosis. Trends Endocrinol Metab 3:224-229
2. Bonjour J-P, Schurch M-A, Rozzori R (1996) Nutritional aspects of hip fracture. Bone 18:1395-1445
3. Yamaguchi M (2002) Isoflavone and bone metabolism: Its cellular mechanism and preventive role in bone loss. J Health Sci 48:209-222
4. Yamaguchi M, Uchiyama S (2003) Effect of carotenoid on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro: The unique anabolic effect of β-cryptoxanthin. Biol Pharm Bull 26:1188-1191
5. Uchiyama S, Sumida T, Yamaguchi M (2004) Oral administration of β-cryptoxanthin induces anabolic effect on bone components in the femoral tissues of rats in vivo. Biol Pharm Bull 27:232-235
6. Yamaguchi M, Uchiyama S (2004) β-Cryptoxanthin stimulates bone formation and inhibits bone resorption in tissue culture in vitro. Mol Cell Biochem 258:137-144
7. Uchiyama S, Yamaguchi M (2005) β-Cryptoxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1 cells. Int J Mol Med 15:675-681
8. Uchiyama S, Yamaguchi M (2005) β-Cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. J Cell Biochem 95:1224-1234
9. Uchiyama S, Yamaguchi M (2004) Inhibitory effect of β-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 67:1297-1305
10. Uchiyama S, Yamaguchi M (2006) β-Cryptoxanthin stimulates apoptotic cell death and suppresses cell function in osteoclastic cells: Change in their related gene expression. J Cell Biochem 98:1185-1195
11. Uchiyama S, Sumida T, Yamaguchi M (2004) Anabolic effect of β-cryptoxanthin on bone components in the femoral tissues of aged rats in vivo and in vitro. J Health Sci 50:491-496
12. Uchiyama S, Yamaguchi M (2005) Oral administration of β-cryptoxanthin prevents bone loss in streptozotocin-diabetic rats in vivo. Biol Pharm Bull 28:1766-1769
13. Uchiyama S, Yamaguchi M (2006) Oral administration of β-cryptoxanthin prevents bone loss in ovariectomized rats. In J Mol Med 17:15-20
14. Yamaguchi M, Igarashi A, Uchiyama S, Sugawara K, Sumida T, Morita S, Ogawa H, Nishitani M, Kajimoto Y (2006) Effect of β-cryptoxanthin on circulating bone metabolic markers: Intake of juice (Citrus Unshiu) supplemented with β-cryptoxanthin has an effect in menopausal women. J Health Sci 52:758-768
15. Yamaguchi M, Oishi H, Suketa Y (1987) Stimulatory effect of zinc on bone formation in tissue culture. Biochem Pharmacol 36:4007-4012
16. Hashizume M, Yamaguchi M (1991) Stimulatory effect of β-alanyl-L-histidinato zinc on cell proliferation is dependent on protein synthesis in osteoblastic MC3T3-E1 cells. Mol Cell Biochem 122:59-64
17. Kishi S, Yamaguchi M (1994) Inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 48:1225-1230
18. Yamaguchi M, Uchiyama S (2004) Receptor activator of NF-κB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Int J Mol Med 14:81-85
19. Yamaguchi M, Kishi S, Hashizume M (1994) Effect of zinc-chelating dipeptides on osteoblastic MC3T3-E1 cells: Activator of aminoacyl-tRNA synthase. Peptides 15:1367-1371
20. Kishi S, Segawa Y, Yamaguchi M (1994) Histomorphological confirmation of the preventive effect of β-alanyl- l -histidinato zinc on bone loss in ovariectomized rats. Biol Pharm Bull 17:862-865
21. Uchiyama S, Ishiyama K, Yamaguchi M (2005) Synergistic effect of β-cryptoxanthin and zinc sulfate on the bone component in rat femoral tissues in vitro: The unique anabolic effect with zinc. Biol Pharm Bull 28:2142-2145
22. Yamaguchi M, Uchiyama S, Ishiyama K, Hashimoto K (2006) Oral administration in combination with zinc enhances β-cryptoxanthin-induced anabolic effects on bone components in the femoral tissues of rats in vivo. Biol Pharm Bull 29:371-374
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
24. Walter K, Schutt C (1965) Acid and alkaline phosphatase in serum. In: Bergmeyer HV (ed) Methods of enzymatic analysis, vols 1-2, Academic Press, New York, pp 856-860
25. Chamczynshi P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
26. Sohn KY, Maity SN, de Crombrugghe B (1994) Studies on the structure of CBF-A isoform generated from an alternatively spliced RNA. Gene 139:147-153
27. Luppen CA, Smith E, Spevak L, Boshey AL, Frenhel B (2003) Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res 18:1186-1197
28. Wilcox FH, Tatlor BA (1981) Genetics of the Akp-2 locus for alkaline phosphatase of liver, kidney, bone, and placenta in the mouse. Linkage with the Ahd-1 locus on chromosome 4. J Hered 72:387-390
29. Desbois C, Hogue DA, Karsenty G (1994) The mouse osteocalcin gene culture contains three genes with two separate spatial and temporal patterns of expression. J Biol Chem 269:1183-1190
30. Yamaguchi M, Sugimoto E, Hachiya S (2001) Stimulatory effect of menaquinone-7 (vitamin K 2) on osteoblastoc bone formation in vitro. Mol Cell Biochem 223:131-137
31. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Tageted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764
32. Majeska RJ, Wnthier RE (1975) Studies on matrix resicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochem Biophys Acta 391:51-60
33. Yamaguchi M, Oishi H, Suketa Y (1998) Zinc stimulation of bone protein synthesis in tissue culture. Activation of bone aminoacyl-tRNA synthase. Biochem Pharmacol 37:4075-4080